Matches in Wikidata for { <http://www.wikidata.org/entity/Q58132250> ?p ?o ?g. }
- Q58132250 description "2018 nî lūn-bûn" @default.
- Q58132250 description "2018 թվականին հրատարակված գիտական հոդված" @default.
- Q58132250 description "2018年の論文" @default.
- Q58132250 description "2018年学术文章" @default.
- Q58132250 description "2018年学术文章" @default.
- Q58132250 description "2018年学术文章" @default.
- Q58132250 description "2018年学术文章" @default.
- Q58132250 description "2018年学术文章" @default.
- Q58132250 description "2018年學術文章" @default.
- Q58132250 description "2018年學術文章" @default.
- Q58132250 description "2018年學術文章" @default.
- Q58132250 description "2018年學術文章" @default.
- Q58132250 description "2018年學術文章" @default.
- Q58132250 description "2018年學術文章" @default.
- Q58132250 description "2018년 논문" @default.
- Q58132250 description "article científic" @default.
- Q58132250 description "article scientific" @default.
- Q58132250 description "article scientifique (publié 2018)" @default.
- Q58132250 description "articol științific" @default.
- Q58132250 description "articolo scientifico (pubblicato il 2018)" @default.
- Q58132250 description "artigo científico (publicado na 2018)" @default.
- Q58132250 description "artigo científico (publicado na 2018)" @default.
- Q58132250 description "artigo científico" @default.
- Q58132250 description "artikull shkencor i botuar më 01 janar 2018" @default.
- Q58132250 description "artikulong pang-agham" @default.
- Q58132250 description "artykuł naukowy" @default.
- Q58132250 description "artículo científico publicado en 2018" @default.
- Q58132250 description "artículu científicu espublizáu en xineru de 2018" @default.
- Q58132250 description "bilimsel makale" @default.
- Q58132250 description "bài báo khoa học" @default.
- Q58132250 description "im Jahr 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58132250 description "mokslinis straipsnis" @default.
- Q58132250 description "naučni članak" @default.
- Q58132250 description "scienca artikolo" @default.
- Q58132250 description "scientific article published on 01 January 2018" @default.
- Q58132250 description "teaduslik artikkel" @default.
- Q58132250 description "tieteellinen artikkeli" @default.
- Q58132250 description "tudományos cikk" @default.
- Q58132250 description "vedecký článok" @default.
- Q58132250 description "vetenskaplig artikel" @default.
- Q58132250 description "videnskabelig artikel (udgivet 2018)" @default.
- Q58132250 description "vitenskapelig artikkel" @default.
- Q58132250 description "vitskapeleg artikkel" @default.
- Q58132250 description "vědecký článek" @default.
- Q58132250 description "wetenschappelijk artikel" @default.
- Q58132250 description "επιστημονικό άρθρο" @default.
- Q58132250 description "мақолаи илмӣ" @default.
- Q58132250 description "мақолаи илмӣ" @default.
- Q58132250 description "наукова стаття, опублікована у 2018" @default.
- Q58132250 description "научна статия" @default.
- Q58132250 description "научная статья" @default.
- Q58132250 description "научни чланак" @default.
- Q58132250 description "научни чланак" @default.
- Q58132250 description "מאמר מדעי" @default.
- Q58132250 description "سائنسی مضمون" @default.
- Q58132250 description "مقالة علمية" @default.
- Q58132250 description "مقالهٔ علمی" @default.
- Q58132250 description "২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q58132250 description "บทความทางวิทยาศาสตร์" @default.
- Q58132250 description "სამეცნიერო სტატია" @default.
- Q58132250 name "Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus" @default.
- Q58132250 name "Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus" @default.
- Q58132250 name "Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus" @default.
- Q58132250 type Item @default.
- Q58132250 label "Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus" @default.
- Q58132250 label "Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus" @default.
- Q58132250 label "Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus" @default.
- Q58132250 prefLabel "Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus" @default.
- Q58132250 prefLabel "Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus" @default.
- Q58132250 prefLabel "Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus" @default.
- Q58132250 P1433 Q58132250-C7F3E916-DFCA-4554-960A-87F711F00ED6 @default.
- Q58132250 P1476 Q58132250-565531D2-0123-4978-B38F-C80888B02601 @default.
- Q58132250 P2093 Q58132250-125D33F2-B2BC-41F7-AAFB-6C52890C3968 @default.
- Q58132250 P2093 Q58132250-13FD5F58-005B-478B-AFE2-DE7DAAA4392A @default.
- Q58132250 P2093 Q58132250-5BAF9288-2E68-4AB7-9BC4-B1D3320E87B9 @default.
- Q58132250 P2093 Q58132250-7D53AC73-8FE3-490A-B88C-C2E587E9AD8E @default.
- Q58132250 P2093 Q58132250-B9102209-27FA-49D0-B2E2-EF4E24338BF6 @default.
- Q58132250 P2093 Q58132250-C90A7DAC-4C25-4F61-9D1F-B938FC06C17C @default.
- Q58132250 P304 Q58132250-4853938E-5F07-425A-A440-2D8B1D61CAF2 @default.
- Q58132250 P31 Q58132250-36C679E5-893B-4983-874A-3F1F3759B033 @default.
- Q58132250 P356 Q58132250-AFE9BD83-CE65-4EC8-BE89-78379D3E2D37 @default.
- Q58132250 P407 Q58132250-5A5915B2-D420-4216-A4D0-BB2B4BD5DC91 @default.
- Q58132250 P433 Q58132250-5DD253CC-DE6E-4EA8-AE23-1C409DF21ABB @default.
- Q58132250 P478 Q58132250-08B13EB2-9CF4-4A6B-9CE8-31D9E4FE662B @default.
- Q58132250 P50 Q58132250-FF620264-1DBE-437C-8C33-850513BC99D8 @default.
- Q58132250 P577 Q58132250-CF3CE2FD-24C7-4A5D-89EE-28EF065FFDD2 @default.
- Q58132250 P698 Q58132250-638C52D5-92F8-4D01-8453-21E7A0FFA951 @default.
- Q58132250 P921 Q58132250-6C665B31-E2BA-4A43-BA73-699C63C57E58 @default.
- Q58132250 P921 Q58132250-7E56ADD6-893A-44DC-9EA7-09E6DE8F7D47 @default.
- Q58132250 P356 BPB.B18-00493 @default.
- Q58132250 P698 30381672 @default.
- Q58132250 P1433 Q15754240 @default.
- Q58132250 P1476 "Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus" @default.
- Q58132250 P2093 "Akira Sasaki" @default.
- Q58132250 P2093 "Hideaki Komatsu" @default.
- Q58132250 P2093 "Kenzo Kudo" @default.
- Q58132250 P2093 "Mami Obara" @default.
- Q58132250 P2093 "Takeshi Chiba" @default.
- Q58132250 P2093 "Yasushi Ishigaki" @default.
- Q58132250 P304 "1722-1726" @default.